9/3/2009 3:07 AM EST
-
Diamyd Medical
Diamyd Medical announced today that the company’s 4-year follow-up of type 1 diabetes patients included in the company’s Phase II study shows a clear positive trend.
Diamyd Medical received approval from the Swedish Medical Products Agency in February to follow up the children and adolescents with type 1 diabetes that were included in the company’s previously reported Phase II study with the diabetes vaccine...